FDA approves new preventive treatment for migraines
The U.S. Food and Drug Administration (FDA) has approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly self-injections.
Pharmacy
Online grocery sales boost Walmart’s Q1 growth
Walmart on Friday reported fiscal first quarter income of $2.1 billion on a 4.4% increase in revenue, to $122.7 billion, thanks largely to a jump in online grocery sales. Walmart’s digital sales increased 33% in the quarter ended April 27.
McKesson HVS partners with Discount Drug Mart
McKesson High Volume Solutions (HVS) announced a pharmacy automation agreement with Discount Drug Mart, Inc., an Ohio-based retail drug store chain that operates more than 70 pharmacies in the state.
Albertsons, Rite Aid unveil merger’s strategies and synergies
Albertsons Cos. and Rite Aid Corp. on Tuesday hosted a joint analyst event to discuss the strategic and financial benefits of the proposed merger transaction between the two companies.
Novartis announces FDA approval of Gilenya
Novartis announced that the U.S. Food and Drug Administration (FDA) has approved Gilenya (fingolimod) for the treatment of children and adolescents 10 to less than 18 years of age with relapsing forms of multiple sclerosis, making it the first disease-modifying therapy indicated for these patients.
NACDS issues memo to chain members on administration’s drug pricing policies
NACDS today sent the following memo to chain members: We are writing to update you on President Trump’s announcement today regarding prescription drug pricing policies, and anticipated future events related to it.
Retailers praise Trump for taking on drug prices
CVS Health and Walgreens have commended President Trump for vowing in a speech today to fight high drug prices.
Metro completes Coutu acquisition
Metro Inc. has completed its $4.5 billion ($3.6 billion U.S.) acquisition of the Jean Coutu Group, creating a food and drug retailer with more than 1,300 stores in Quebec, Ontario and New Brunswick.
PANTHERx selected by Otsuka to distribute Jynarque
PANTHERx Specialty Pharmacy has been selected by Otsuka America Pharmaceutical, Inc. to distribute Jynarque (tolvaptan), the only FDA-approved therapy for patients diagnosed with autosomal dominant polycystic kidney disease (ADPKD).
Express Scripts shows SafeGuardRx program offering better care at lower cost
Express Scripts released new data today showing significantly improved clinical outcomes and lower drug spending for patients with complex, high-cost conditions who are enrolled in a suite of technology-supported, value-based SafeGuardRx programs.
Sentara RMH Medical Center partners with Omnicell to enhance efficiency
Omnicell announced that Sentara RMH Medical Center, part of Sentara Healthcare in Virginia and northeastern North Carolina, has chosen to enhance control, efficiency and safety of its medication management processes with Omnicell’s newest central pharmacy automation, part of the company’s industry-
Diplomat Pharmacy names Griffin CEO
Diplomat Pharmacy Inc. announced that its board of directors has appointed Brian Griffin, executive vice president and chief executive officer of IngenioRx, the pharmacy benefit manager (PBM) of Anthem, as chief executive officer and chairman of the board of directors, effective June 4.
2018 Asembia Pharmacy Summit draws record crowds
The Asembia 2018 Specialty Pharmacy Summit set a new attendance record with over 6,500 attendees last week at the Wynn and Encore here. This is the thirteenth consecutive attendance record set by Asembia, reflecting the growth in specialty pharmacy.